Search

Search Constraints

You searched for: Author/Creator Pul, Refik

Search Results

2. Autoimmune glomerulonephritis in a multiple sclerosis patient after cladribine treatment. (October 2021)

3. CDP-choline is not protective in the SOD1-G93A mouse model of ALS. Issue 4 (1st May 2013)

5. Combination of agomelatine and bupropion for treatment‐resistant depression: results from a chart review study including a matched control group. Issue 4 (19th February 2015)

6. Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization. Issue 1 (December 2017)

7. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

8. Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCENMO Study. (15th March 2022)

9. Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease: CHANCENMO Study. (15th March 2022)

10. CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls. (10th September 2015)